From Oversight to Intelligence: Reimagining Post-approval Life Sciences with AI

AI is reshaping the future of post-approval life sciences. From predictive pharmacovigilance and regulatory intelligence to enhanced patient engagement, organizations are leveraging AI technologies to transform compliance-focused operations into intelligence-driven ecosystems.

From Oversight to Intelligence: Reimagining Post-approval Life Sciences with AI is an Everest Group research report supported by Wipro. The report explores how life sciences organizations can leverage AI, Generative AI, and Agentic AI to enhance operational intelligence, strengthen compliance, and create value across the product lifecycle. It also examines the governance, human oversight, and trusted AI frameworks required to scale AI adoption responsibly and effectively.

The report also highlights emerging opportunities to apply AI across key post-approval functions, helping organizations improve decision-making, streamline complex processes, and derive actionable insights from growing volumes of data. As life sciences companies navigate evolving regulatory and market demands, AI-enabled operating models can help enhance agility, efficiency, and long-term business value.

Complete the form to download the report and learn how AI-enabled operating models can help advance intelligence-led post-approval operations.